Revenue: The sum of all revenue fields included for a company's operating activities.
VYNE Therapeutics Inc. (VYNE) had Revenue of $0.13M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$0.13M |
$-4.84M |
|
-- |
|
$0.13M |
|
$5.35M |
|
$-5.22M |
|
$0.26M |
|
$-4.96M |
|
$-4.96M |
|
$-4.96M |
|
$-4.96M |
|
$-4.84M |
|
$-4.96M |
|
$-5.22M |
|
$-5.30M |
|
42.77M |
|
42.77M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$30.01M |
|
$0.09M |
|
$0.15M |
|
$30.16M |
|
$2.40M |
|
-- |
|
-- |
|
$2.40M |
|
$27.77M |
|
$27.77M |
|
$27.77M |
|
33.32M |
|
| Cash Flow Statement Financials | |
$-33.12M |
|
$37.37M |
|
$-0.14M |
|
$19.93M |
|
$24.03M |
|
$4.10M |
|
$2.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4013.85% |
|
-4013.85% |
|
-- |
|
-3812.31% |
|
-3720.77% |
|
$-33.12M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-17.86% |
|
-17.86% |
|
-16.45% |
|
-17.86% |
|
$0.83 |
|
$-0.77 |
|
$-0.77 |
|